Online citations, reference lists, and bibliographies.
← Back to Search

Oral Delivery Of Lactoferrin: A Review

Xudong Yao, C. Bunt, J. Cornish, S. Quek, Jingyuan Wen
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Lactoferrin (Lf), as a therapeutic protein drug, has attracted much interest due to its many important roles in human and animal health and development. Oral delivery offers the most convenient way for supplementing Lf. However, the bioavailability of orally administered Lf is limited by a number of barriers associated with protein absorption. During the past decade, several oral delivery systems have been developed to preserve Lf stability in order to enhance gastric residence time and improve its bioavailability. This review summarizes various pharmaceutical strategies currently under investigation including: PEGylation, absorption enhancers, enzymatic inhibitors and advanced drug carrier systems.
This paper references
10.1038/jcbfm.2009.104
Brain-Targeting Mechanisms of Lactoferrin-Modified DNA-Loaded Nanoparticles
R. Huang (2009)
10.1016/j.jconrel.2008.10.016
Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.
Kai-li Hu (2009)
10.1093/JN/126.3.634
Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion.
J. Reseland (1996)
10.1016/S0168-3659(97)00136-3
Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates.
A. Bernkop-Schnürch (1998)
10.1016/0168-3659(95)00187-5
Effects of bile salts on transport rates and routes of FITC-labelled compounds across porcine buccal epithelium in vitro
A. Hoogstraate (1996)
10.1023/A:1018927402875
Formulation and Intestinal Absorption Enhancement Evaluation of Water-in-Oil Microemulsions Incorporating Medium-Chain Glycerides
P. Constantinides (2004)
10.1007/978-1-4757-9068-9_2
Structures of Buffalo and Mare Lactoferrins
A. Sharma (1998)
10.1016/J.IJPHARM.2007.08.057
Stable drug encapsulation in micelles and microemulsions.
A. Narang (2007)
10.1016/0378-4274(85)90160-2
Effects of surfactants on the permeability of canine oral mucosa in vitro.
I. A. Siegel (1985)
10.1016/j.ejpb.2008.08.016
In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery.
Ana Figueiras (2009)
Preparation and in vitro
H Onishi (2007)
10.1016/J.BIOMATERIALS.2004.07.047
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
S. Balthasar (2005)
10.2174/138161207780363095
Antibiotic properties and applications of lactoferrin.
E. Weinberg (2007)
Bernkop-Schnurch A (2008) In vitro enhancing effect of 1-dodecylazacycloheptan-2-evaluation of natural and methylated cyclodextrins as buccal
A Figueiras (2008)
Stable drug encapsulation
AS Narang (2006)
10.1042/BJ20031253
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
Enzymatic barriers to peptide and protein drug delivery. In: Lee VHL (ed) Peptide and protein drug
VHL Lee (1991)
10.1211/0022357044959
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
L. Hu (2004)
10.1248/BPB.33.1253
Amino group PEGylation of bovine lactoferrin by linear polyethylene glycol-p-nitrophenyl active esters.
K. Kato (2010)
10.1016/J.JCONREL.2006.04.012
Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Y. Sudhakar (2006)
10.1023/A:1018968611962
Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats
A. Yamamoto (2004)
10.1002/JPS.2600770107
Vasopressin: a model for the study of effects of additives on the oral and rectal administration of peptide drugs.
M. Saffran (1988)
10.1016/J.JCONREL.2007.10.023
Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes.
Nartaya Thirawong (2008)
10.1016/j.biochi.2008.05.021
Twenty-five years of research on bovine lactoferrin applications.
M. Tomita (2009)
10.1023/A:1016009313548
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
10.1111/J.1365-2621.2006.TB15606.X
Utilization of Lactoferrin as an Iron‐Stabilizer for Soybean and Fish Oil
M. Shiota (2006)
10.1007/s10534-010-9312-6
Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells
A. Roșeanu (2010)
10.1016/S1773-2247(04)50081-3
A study of insulin-chitosan complex nanoparticles used for oral administration
F. Cui (2004)
10.1016/S0168-3659(99)00042-5
Optimizing oral absorption of peptides using prodrug strategies.
R. Borchardt (1999)
Twenty - five years of research on bovine lactoferrin application
M Tomita (2009)
The effect of physical barriers
N Puri (1998)
10.1016/S0169-409X(00)00127-7
The potential use of receptor-mediated endocytosis for oral drug delivery.
G. Russell-Jones (2001)
Novel preparation of enteric
H Onishi (2008)
Int J Pept Res Ther
(2013)
Oral delivery of insulin A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats
Yw Cho (1989)
10.1016/J.EJPS.2005.02.008
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
10.1016/S0168-3659(02)00411-X
Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
H. Takeuchi (2003)
10.1128/IAI.62.6.2628-2632.1994
Lactoferrin is a lipid A-binding protein.
B. Appelmelk (1994)
10.2174/138920007780866834
Presystemic metabolism of orally administered peptide drugs and strategies to overcome it.
A. Bernkop-Schnürch (2007)
10.1016/J.IJPHARM.2005.04.016
A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats.
A. Cilek (2005)
10.1002/1520-6017(200007)89:7<951::AID-JPS13>3.0.CO;2-1
Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
M. Thanou (2000)
10.1292/JVMS.63.637
Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus.
M. E. Murphy (2001)
10.1016/j.fct.2009.03.030
PEGylated lactoferrin enhanced its hepatoprotective effects on acute liver injury induced by carbon tetrachloride in rats.
A. Sugiyama (2009)
10.1080/03639040601085334
Preparation and In Vitro Characteristics of Lactoferrin-loaded Chitosan Microparticles
H. Onishi (2007)
10.1023/A:1012108118670
Novel Bioadhesive Chitosan-EDTA Conjugate Protects Leucine Enkephalin from Degradation by Aminopeptidase N
A. Bernkop-Schnürch (2004)
10.1016/J.CIS.2006.11.016
Microemulsions as carriers for drugs and nutraceuticals.
Aviram Spernath (2006)
10.1023/B:BIOM.0000027707.82911.be
The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1
B. Berkhout (2004)
10.1038/labinvest.2010.80
Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis
E. Yamano (2010)
10.1016/S0378-5173(97)00325-6
Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A
Z. Gao (1998)
10.1016/0378-5173(92)90341-X
A study on factors influencing the droplet size in nonionic oil-in-water microemulsions
D. Attwood (1992)
10.1248/BPB.19.897
Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats.
T. Kimura (1996)
10.1172/JCI115407
Killing of gram-negative bacteria by lactoferrin and lysozyme.
R. Ellison (1991)
A (2009) Lactoferrin conjugated
A Sugiyama (2009)
10.1615/CRITREVTHERDRUGCARRIERSYST.V20.I23.30
Emerging trends in oral delivery of peptide and protein drugs.
R. Mahato (2003)
10.1248/YAKUSHI.129.1507
Preparation and in vitro evaluation of chitosan-coated alginate/calcium complex microparticles loaded with fluorescein-labeled lactoferrin.
Ken-ichi Koyama (2009)
10.1139/O01-230
Bovine lactoferrin and lactoferricin derived from milk: production and applications.
M. Tomita (2002)
10.1016/J.EJPB.2007.06.016
Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system.
Tomoko Oosegi (2008)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
10.2337/diacare.13.9.911
Insulin Administration via Liposomes
R. S. Spangler (1990)
10.1097/ALN.0b013e318182a486
Physicochemical Properties, Pharmacokinetics, and Pharmacodynamics of a Reformulated Microemulsion Propofol in Rats
Eun-Ho Lee (2008)
10.1021/JF0492316
Effects of lactoferrin, phytic acid, and EDTA on oxidation in two food emulsions enriched with long-chain polyunsaturated fatty acids.
N. Nielsen (2004)
10.1023/A:1014220832384
The Potential of Chitosan in Enhancing Peptide and Protein Absorption Across the TR146 Cell Culture Model—An in Vitro Model of the Buccal Epithelium
A. Portero (2004)
10.1023/A:1011920530771
Nitric Oxide Donors Enhance Rectal Absorption of Macromolecules in Rabbits
N. Utoguchi (2004)
10.1208/pt070370
5-methyl-pyrrolidinone chitosan films as carriers for buccal administration of proteins
C. Colonna (2008)
Enzymatic barriers to peptide and protein drug delivery
Lee VHL (1991)
10.1021/bc800258v
Development of poly(ethylene glycol) conjugated lactoferrin for oral administration.
Y. Nojima (2008)
10.1139/O01-239
Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies.
H. Tsuda (2002)
10.1006/JMBI.2001.4692
Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6 A resolution and structural basis of its dual role.
J. Khan (2001)
10.1016/0300-9629(93)90342-2
Peptide and protein drug delivery
V. Lee (1991)
10.1248/BPB.28.1717
Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration.
A. Ishikado (2005)
10.1016/J.BIOMATERIALS.2007.09.024
The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.
R. Huang (2008)
10.1016/S1461-5347(98)00100-X
Macromolecules as safe penetration enhancers for hydrophilic drugs—a fiction?
H. Junginger (1998)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1016/j.brainresbull.2009.12.008
Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo
R. Huang (2010)
10.1046/J.1471-4159.1997.69041709.X
Characterization of in vitro glycation sites of tau.
P. Nacharaju (1997)
10.1093/JN/132.9.2597
Orally ingested human lactoferrin is digested and secreted in the upper gastrointestinal tract in vivo in women with ileostomies.
F. Troost (2002)
Bioadhesive polysaccharide in protein
YJ Li (1997)
10.1016/J.IJPHARM.2007.07.047
Linker-based lecithin microemulsions for transdermal delivery of lidocaine.
Jessica S Yuan (2008)
10.1016/J.IJPHARM.2006.07.026
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
N. Zhang (2006)
10.1023/B:BIOM.0000027697.83706.32
Protection against infections by oral lactoferrin: Evaluation in animal models
S. Teraguchi (2004)
10.1016/S0032-3861(98)00549-7
Enzymatic degradation of poly(ε-caprolactone)/poly(dl-lactide) blends in phosphate buffer solution
Z. Gan (1999)
10.1023/A:1016488623022
Mucoadhesive Polymers in Peroral Peptide Drug Delivery. VI. Carbomer and Chitosan Improve the Intestinal Absorption of the Peptide Drug Buserelin In Vivo
H. L. Luessen (2004)
10.1248/BPB.33.1758
Human trial of liposomal lactoferrin supplementation for periodontal disease.
A. Ishikado (2010)
10.1023/A:1015947509295
The Adjuvant Effect of Bacitracin on Nasal Absorption of Gonadorelin and Buserelin in Rats
Susanne Raehs (2004)
Evidence for a direct antitumor mechanism of action of bovine lactoferricin.
L. T. Eliassen (2002)
10.1016/0166-6622(81)80064-9
The definition of microemulsion
Ingvar Danielsson (1981)
10.1016/0024-3205(75)90272-6
Purification and properties
B. Cox (1975)
10.1111/J.1432-1033.1991.TB15801.X
Molecular cloning and sequence analysis of bovine lactotransferrin.
A. Pierce (1991)
10.1016/S0140-6736(89)92954-1
ORAL DELIVERY OF INSULIN
YoughW. Cho (1989)
Lactoferrin conjugated with 40-kDA branched PEG has and improved circulating halflife
Y Nojima (2009)
10.1016/S0939-6411(98)00015-0
Preparation and characterization of nanoparticles containing an antihypertensive agent.
M. Leroueil-Le Verger (1998)
10.1074/JBC.M405155200
Prolonging the Action of Protein and Peptide Drugs by a Novel Approach of Reversible Polyethylene Glycol Modification*
H. Tsubery (2004)
10.1016/S0378-5173(96)04861-2
Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches
Shinji Sakuma (1997)
10.1006/JMBI.1997.1386
Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution.
S. Moore (1997)
10.2174/1389557023406007
Biomembrane permeability of peptides: strategies to improve their mucosal uptake.
A. Bernkop-Schnürch (2002)
10.3891/ACTA.CHEM.SCAND.14-0510
Isolation of an iron-containing red protein from human milk.
B. Johanson (1960)
10.1017/S0022029910000622
Characterization of lactoferrin oil-in-water emulsions and their stability in recombined milk.
A. Acero-Lopez (2010)
10.1016/J.JCONREL.2005.12.015
Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
C. Prego (2006)
10.1139/O06-057
Lactoferrin and bone; structure-activity relationships.
J. Cornish (2006)
10.2174/138920106777950852
Novel delivery technologies for protein and peptide therapeutics.
T. Kumar (2006)
10.1517/17425247.1.1.87
Thiomers for oral delivery of hydrophilic macromolecular drugs
A. Bernkop-Schnürch (2004)
10.2174/138161210793292555
Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization.
L. Gentilucci (2010)
10.1016/S0169-409X(02)00022-4
Chemistry for peptide and protein PEGylation.
M. Roberts (2002)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.1007/s11095-009-9925-z
Lactoferrin Conjugated with 40-kDa Branched Poly(ethylene Glycol) Has an Improved Circulating Half-Life
Y. Nojima (2009)
10.1128/IAI.56.5.1144-1149.1988
Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis.
A. Schryvers (1988)
10.1016/0005-2744(80)90202-8
Purification and properties of human intestine alanine aminopeptidase.
J. McClellan (1980)
10.5860/choice.42-2552a
Encyclopedia of nanoscience and nanotechnology
H. Nalwa (2011)
10.1023/A:1011929016601
Chitosan and Its Use as a Pharmaceutical Excipient
L. Ilium (1998)
10.2174/187221108786241679
Microemulsions: a novel approach to enhanced drug delivery.
S. Talegaonkar (2008)
10.1016/S0169-409X(98)00037-4
The effect of physical barriers and properties on the oral absorption of particulates.
Norris (1998)
10.1007/s11095-009-9897-z
Nanoparticulate Systems for Growth Factor Delivery
S. Zhang (2009)
10.1021/JS950477M
Oral administration of recombinant human erythropoietin in liposomes in rats: influence of lipid composition and size of liposomes on bioavailability.
Y. Maitani (1996)
10.1016/0169-409X(95)00131-P
The potential use of receptor-mediated endocytosis for oral drug delivery 1 PII of original article:
G. Russell-Jones (1996)
Effects of various protease inhibitors on protein degradation of cultured myotubes
Paiyen Wu (1996)
10.1016/j.ejpb.2009.03.008
In vivo evaluation of thiolated poly(acrylic acid) as a drug absorption modulator for MRP2 efflux pump substrates.
M. Greindl (2009)
Adjuvant effects of glyceryl
T Nishihata (1983)
10.1201/9781498710565
Colloidal Drug Delivery Systems
J. Kreuter (1994)
10.1016/0304-4165(76)90294-4
Hypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soybean trypsin inhibitor.
R. Melmed (1976)
10.1107/S0907444999010951
Structure of buffalo lactoferrin at 2.5 A resolution using crystals grown at 303 K shows different orientations of the N and C lobes.
S. Karthikeyan (1999)
Preparation and in vitro evaluation of chitosancoated alginate / calcium complex microparticles loaded with fluoresceinlabeled lactoferrin
H Onishi (2009)
10.1016/0005-2795(76)90112-4
The effect of trypsin on bovine transferrin and lactoferrin.
J. Brock (1976)
10.1248/CPB.42.1954
Mucoadhesion of polymer-coated liposomes to rat intestine in vitro.
H. Takeuchi (1994)
10.1055/S-2007-1003642
Liposome-entrapped calcitonin and parathyroid hormone are orally effective in rats.
Masao Fukunaga (1991)
inulin in rabbits
GJ Noh (2008)
10.1016/J.INTIMP.2007.05.019
Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues.
R. Fischer (2007)
Development of a colonic release capsule dosage form and the absorption of insulin.
M. Kraeling (1992)
10.1128/AAC.47.8.2619-2623.2003
Oral Lactoferrin Treatment of Experimental Oral Candidiasis in Mice
N. Takakura (2003)
10.1016/S0168-3659(97)00204-6
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
A. Bernkop-Schnürch (1998)
10.1007/s11095-005-7894-4
In Vitro Evaluation of Various Buccal Permeation Enhancing Systems for PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide)
N. Langoth (2005)
10.1292/JVMS.66.149
Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis.
K. Hayashida (2004)
Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation
L Penkler (1999)
10.1016/S0168-3659(03)00126-3
Chitosan-based gastrointestinal delivery systems.
Radi Hejazi (2003)
10.3109/03639040903567109
Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats
H. Onishi (2010)
10.1016/S0378-5173(02)00461-1
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.
M. H. El-Shabouri (2002)
10.1093/JN/131.8.2121
Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats.
H. Kuwata (2001)
10.1111/j.2042-7158.1985.tb03064.x
Promoting effect of the new chymotrypsin inhibitor FK‐448 on the intestinal absorption of insulin in rats and dogs
S. Fujii (1985)
10.1111/j.2042-7158.1994.tb03716.x
Metabolism and Transport of the Pentapeptide Metkephamid by Brush‐border Membrane Vesicles of Rat Intestine
P. Langguth (1994)
10.1016/0378-5173(92)90005-M
Effect of organic acids, trypsin inhibitors and dietary protein on the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats
Ushirogawa Yoshiteru (1992)
Structures of buffalo and mare lactoferrins. Similarities, differences, and flexibility.
A. Sharma (1998)
10.1021/JF9809939
Effect of lactoferrin on oxidative stability of corn oil emulsions and liposomes.
S. Huang (1999)
10.1358/DOF.1999.024.11.858633
The role of sorption promoters in increasing the bioavailability of drugs in oral preparations
P. Sharma (1999)
10.1007/s004300050093
Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin
M. Marchetti (1999)
10.1021/jf100703c
Impact of interfacial composition on physical stability and in vitro lipase digestibility of triacylglycerol oil droplets coated with lactoferrin and/or caseinate.
U. Lesmes (2010)
10.1152/AJPGI.1994.267.2.G308
Apical-to-basolateral transepithelial transport of human lactoferrin in the intestinal cell line HT-29cl.19A.
T. Mikogami (1994)
10.1111/J.1365-2125.1995.TB05722.X
Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion.
A. Trull (1995)
10.1111/j.2042-7158.1985.tb03056.x
Characterization of enhanced intestinal permeability; electrophysiological study on the effects of diclofenac and ethylenediaminetetraacetic acid
S. Yamashita (1985)
Nanoparticle drug delivery to the brain
K Ringe (2004)
The protein in whey
M Soerensen (1939)
10.1615/CRITREVTHERDRUGCARRIERSYST.V22.I5.10
Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.
S. Galindo-Rodriguez (2005)
10.1002/JPS.2600720318
Adjuvant effects of glyceryl esters of acetoacetic acid on rectal absorption of insulin and inulin in rabbits.
T. Nishihata (1983)



This paper is referenced by
FORMULATION FOR ORAL ADMINISTRATION OF LACTOFERRIN VIA ENCAPSULATION IN BOVINE SERUM ALBUMIN AND TANNIC ACID MULTILAYERS
Ece Kılıç (2018)
10.2174/1389203720666190513085839
Strategies for oral delivery of metal-saturated lactoferrin.
Przemysław Gajda-Morszewski (2019)
10.1080/10408398.2017.1381583
Lactoferrin: Structure, function, denaturation and digestion
B. Wang (2019)
10.1016/j.xphs.2019.02.025
Lactoferrin-Loaded Alginate Microparticles to Target Clostridioides difficile Infection.
Shwana Braim (2019)
10.1007/s11307-019-01390-x
Lactoferrin Protects Hyperoxia-Induced Lung and Kidney Systemic Inflammation in an In Vivo Imaging Model of NF-κB/Luciferase Transgenic Mice
C. Yen (2019)
10.1038/srep44159
Formulation for Oral Delivery of Lactoferrin Based on Bovine Serum Albumin and Tannic Acid Multilayer Microcapsules
Ece Kılıç (2017)
10.1016/J.IDAIRYJ.2016.09.001
Mild thermal treatment and in-vitro digestion of three forms of bovine lactoferrin: Effects on functional properties
B. Wang (2017)
10.3390/SEPARATIONS4020010
Optimization of Lactoperoxidase and Lactoferrin Separation on an Ion-Exchange Chromatography Step
Naeimeh Faraji (2017)
10.1002/bbb.2100
Valorization of whey using a biorefinery
J. L. Sebastián-Nicolás (2020)
10.1007/s40199-019-00316-w
Review of recently used techniques and materials to improve the efficiency of orally administered proteins/peptides
Y. H. Y. Ibrahim (2019)
10.2174/0929867326666190503121546
Lactoferrin in Bone Tissue Regeneration.
M. Icriverzi (2019)
10.3390/nu12092562
Lactoferrin from Bovine Milk: A Protective Companion for Life
F. Superti (2020)
Semantic Scholar Logo Some data provided by SemanticScholar